Cell Kinetics Analysis
Cell Kinetics' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Cell Kinetics' financial risk is the risk to Cell Kinetics stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Cell Kinetics' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Cell Kinetics is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Cell Kinetics to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Cell Kinetics is said to be less leveraged. If creditors hold a majority of Cell Kinetics' assets, the Company is said to be highly leveraged.
Cell Kinetics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Cell Kinetics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Cell Kinetics is worth, separate from its market price. There are two main types of Cell Kinetics' stock analysis: fundamental analysis and technical analysis.
The Cell Kinetics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cell Kinetics' ongoing operational relationships across important fundamental and technical indicators.
Cell |
Cell Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.09. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cell Kinetics recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. Cell Kinetics Ltd. engages in the refining and commercialization of CellScan and related technology. Cell Kinetics Ltd. is a subsidiary of Medis Technologies Ltd. Cell Kinetics operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 10 people.The quote for Cell Kinetics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Cell Kinetics please contact the company at 972 8 918 8667 or go to http://www.cellkinetics.com.Cell Kinetics Investment Alerts
| Cell Kinetics is not yet fully synchronised with the market data | |
| Cell Kinetics has some characteristics of a very speculative penny stock | |
| Cell Kinetics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 21 K. Net Loss for the year was (2.38 M) with profit before overhead, payroll, taxes, and interest of 7 K. | |
| Cell Kinetics has accumulated about 4 K in cash with (2.27 M) of positive cash flow from operations. |
Cell Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 10 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cell Kinetics's market, we take the total number of its shares issued and multiply it by Cell Kinetics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Cell Kinetics Outstanding Bonds
Cell Kinetics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cell Kinetics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cell bonds can be classified according to their maturity, which is the date when Cell Kinetics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Cell Kinetics Debt to Cash Allocation
Many companies such as Cell Kinetics, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has a current ratio of 3.88, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Cell Kinetics until it has trouble settling it off, either with new capital or with free cash flow. So, Cell Kinetics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cell Kinetics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cell to invest in growth at high rates of return. When we think about Cell Kinetics' use of debt, we should always consider it together with cash and equity.Cell Kinetics Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Cell Kinetics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Cell Kinetics, which in turn will lower the firm's financial flexibility.Cell Kinetics Corporate Bonds Issued
Most Cell bonds can be classified according to their maturity, which is the date when Cell Kinetics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Cell Kinetics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Cell Pink Sheet
If you are still planning to invest in Cell Kinetics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cell Kinetics' history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |